Zobrazeno 1 - 10
of 1 862
pro vyhledávání: '"Ho SA"'
Publikováno v:
DAEDONG MUNHWA YEON'GU. :169-196
Publikováno v:
Infection Control & Hospital Epidemiology. 41:s216-s217
Background: Acute-care hospitals began reporting methicillin-resistant Staphylococcus aureus (MRSA) LabID facility-wide inpatient events to the NHSN in 2013. Few data are available regarding the epidemiology of these patients. Methods: We conducted a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
park su mil
Publikováno v:
The Classical Literature and Education. :229-258
Publikováno v:
Infection Control & Hospital Epidemiology; October 2020, Vol. 41 Issue: Supplement 1 ps216-s217, 2p
Autor:
Budzinski, Kristi, Blewis, Megan, Dahlin, Philip, D'Aquila, Daniel, Esparza, Julia, Gavin, Jack, Ho, Sa V., Hutchens, Clarice, Kahn, David, Koenig, Stefan G., Kottmeier, Robert, Millard, Jeff, Snyder, Matt, Stanard, Brad, Sun, Lixin
Publikováno v:
In New BIOTECHNOLOGY 25 March 2019 49:37-42
Autor:
Wong DD; National Measurement Institute, Lindfield, Sydney, New South Wales., Ho SA; Peter MacCallum Cancer Centre.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria., Domazetovska A; Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Sydney, New South Wales., Yong MK; Peter MacCallum Cancer Centre.; Department Infectious Diseases, Royal Melbourne Hospital.; National Centre for Infections in Cancer, Parkville., Rawlinson WD; Serology and Virology Division, NSW Health Pathology, Prince of Wales Hospital, Sydney, New South Wales.; Schools of Biomedical Sciences, Biotechnology and Biomolecular Sciences, Clinical Sciences, University of NSW, Sydney New South Wales, Australia.
Publikováno v:
Current opinion in infectious diseases [Curr Opin Infect Dis] 2023 Dec 01; Vol. 36 (6), pp. 505-513. Date of Electronic Publication: 2023 Sep 19.
Publikováno v:
In Biochemical Engineering Journal 15 April 2016 108:84-97
Autor:
Neoh CF; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia., Chen SCA; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Westmead Hospital, Sydney, Australia.; The University of Sydney Institute of Infectious Diseases, Sydney Medical School, Faculty of Medicine and Health, University of Sydney, Sydney, Australia., Kong DCM; The National Centre for Antimicrobial Stewardship, The Peter Doherty Institute for Infections and Immunity, Melbourne, Australia.; Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Melbourne, Australia.; Pharmacy Department, Grampians Health-Ballarat, Melbourne, Australia.; School of Medicine, Deakin University, Geelong, Australia., Hamilton K; Centre for Infectious Diseases and Microbiology Laboratory Services, New South Wales Health Pathology, Westmead Hospital, Sydney, Australia., Nguyen QA; Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital Sydney, Sydney, Australia.; Kolling Institute, Northern Sydney Local Health District and the Faculty of Medicine and Health, The University of Sydney, Sydney, Australia., Spelman T; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Australia., Tew M; Health Economics Unit, Centre for Health Policy Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia., Harvey EL; F2G Ltd, Manchester, UK., Ho SA; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia., Saunders NR; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia., Tennakoon S; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia., Crowe A; Department of Infectious Diseases, St Vincent's Hospital Melbourne, Melbourne, Australia., Marriott D; Department of Clinical Microbiology and Infectious Diseases, St Vincent's Hospital Sydney, Sydney, Australia., Trubiano JA; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.; Department of Infectious Diseases, Austin Hospital, Melbourne, Australia., Slavin MA; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
Publikováno v:
The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2024 Jan 03; Vol. 79 (1), pp. 46-54.
Publikováno v:
In International Journal of Pharmaceutics 10 September 2013 453(2):533-540